These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2512638)

  • 21. Fibrinolytic activity in end-stage renal disease.
    Hong SY; Yang DH
    Nephron; 1993; 63(2):188-92. PubMed ID: 8450911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
    Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urokinase-like plasminogen activator increased in plasma after alcohol drinking.
    Sumi H; Hamada H; Tsushima H; Mihara H
    Alcohol Alcohol; 1988; 23(1):33-43. PubMed ID: 3128990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin.
    Braat EA; Jie AF; Ronday HK; Beekman B; Rijken DC
    Ann Rheum Dis; 2000 Apr; 59(4):315-8. PubMed ID: 10733483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinolytic system in plasma and pleural fluid in malignant pleural mesothelioma.
    Ozdemir O; Emri S; Karakoca Y; Sayinalp N; Akay H; Dündar S; Bariş I
    Thromb Res; 1996 Oct; 84(2):121-8. PubMed ID: 8897701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.
    Kamper EF; Kopeikina LT; Koutsoukos V; Stavridis J
    J Rheumatol; 1997 Feb; 24(2):262-8. PubMed ID: 9034981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment.
    Pawlak K; Buraczewska-Buczko A; Mysliwiec M; Pawlak D
    Am J Med Sci; 2010 Jan; 339(1):5-9. PubMed ID: 19926968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon reaction of leukocytes in diffuse connective tissue diseases].
    Pitenov VA; Etkind GV; Bektemirov TA; Alekberova ZS; Barinskiĭ IF
    Sov Med; 1976 Dec; (12):21-6. PubMed ID: 1013787
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood urokinase plasminogen activator system in chronic urticaria.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombosis in systemic lupus erythematosus: role of impaired fibrinolysis.
    Dhillon PK; Adams MJ
    Semin Thromb Hemost; 2013 Jun; 39(4):434-40. PubMed ID: 23504607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced T lymphoid colony growth in patients with progressive systemic sclerosis and rheumatoid arthritis.
    Winkelstein A; Bernstein ML; Stevens MA; Rodnan GP; Medsger TA; Dobson SA
    J Lab Clin Med; 1982 Aug; 100(2):240-7. PubMed ID: 6980249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas.
    Alonso DF; Farías EF; Bal de Kier Joffé E
    Cancer Lett; 1993 Jul; 70(3):181-7. PubMed ID: 8353814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Díaz-Gomez F; Pacheco-Pantoja E; Drenkard C; Alarcón-Segovia D
    Am J Hematol; 1991 May; 37(1):9-13. PubMed ID: 1902623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma.
    Dooijewaard G; de Boer A; Turion PN; Cohen AF; Breimer DD; Kluft C
    Thromb Haemost; 1991 Jan; 65(1):82-6. PubMed ID: 1902597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolytic activity in renal venous blood in man.
    Schrader J; Neuhaus KL; Tebbe U; Köstering H; Scheler F
    Klin Wochenschr; 1986 Jul; 64(13):587-9. PubMed ID: 3747416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis.
    Huber K; Kirchheimer JC; Korninger C; Binder BR
    Thromb Res; 1991 Jun; 62(5):491-500. PubMed ID: 1910213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.